Syneos Health, Inc.
SYNH · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $4 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $7 | $6 | $7 | $8 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 0.7% | -0.2% | 1.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 21.6% | 19.8% | 23.4% | 23.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7.2% | 6.5% | 9.1% | 13.9% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 0.1% | -5.3% | 4.1% | 6.5% |
| EPS Diluted | 0.01 | -0.7 | 0.54 | 0.84 |
| % Growth | 101.4% | -229.6% | -35.7% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |